As of this week, three new options are available for generic Sunovion Pharmaceuticals Inc’s Lunesta (eszopiclone), a pharmacological treatment for insomnia. Pittsburgh-based Mylan Inc launched Eszopiclone Tablets 1 mg, 2...
Read MoreHyderabad, India-based Dr. Reddy’s Laboratories has launched Eszopiclone Tablets (C-IV) 1 mg, 2 mg, and 3 mg, a therapeutic equivalent generic version of Lunesta (eszopiclone) tablets C-IV in the US market. Dr. Reddy’s...
Read More
Research carried out at the Edinburgh International Science Festival has discovered what people’s...
Read MoreNews-medical.net reports on the new “Sleep Condition Indicator” that is a screening tool for insomnia. UK researchers have developed a “brief but versatile” tool, based on standard diagnostic criteria, to screen...
Read MoreThe UK’s Daily Mail recently published a fascinating article about nightmares may say about a person’s health, from revealing that a child is being bullied to warning signs of an impending illness to being linked to...
Read More